1. ANTICONVULSANT SERUM LEVELS ARE USEFUL ONLY IF THE PHYSICIAN APPROPRIATELY USES THEM: AN ASSESSMENT OF THE IMPACT OF PROVIDING SERUM LEVEL DATA TO PHYSICIANS - R.S Beardsley et al., Epilepsia, 24:330-335
2. PROBLEMS OF COMBINATION DRUG THERAPY IN CHILDREN - B.F.D Bourgeois, Epilepsia, 29(suppl.3):S20-S24 1988
3. CHILDHOOD EPILEPSY: PHARMACOLOGICAL CONSIDERATIONS - B.F.D Bourgeois, Acta. Neurol. Scand., 86(suppl.140):23-27 1992
4. ESTABLISHED ANTICONVULSANTS AND TREATMENT OF REFRACTORY EPILEPSY - M.J Brodie, Lancet., 336:350-354 1990
5. COMPARATIVE PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS M. Bialer, Clin. Pharmacokinet, 24:441-452 1993
6. BENZODIAZEPINES IN THE TREATMENT OF EPILEPSY - t.R Browne et al., Epilepsia, 14:277-310 1973
7. PHARMACOKINETIC PITTFALLS OF PRESENT ANTIEPILEPTIC MEDICATIONS - J. Coyd., Epilepsia, 32 (suppl.5):S53-S65 1991
8. SPECIAL PHARMACOKINETIC CONSIDERATIONS IN CHILDREN - E. Dodson., Epilepsia., 28:S56-S70 1987
9. UNWANTED EFFECTS OF ANTICONVULSANT DRUGS - M.J Eadie., In: The Treatment of Epilepsy edited by J.H Tyrer, pp.129-160 MT Press 1980
10. MANAGING PEDIATRIC EPILEPSY SYNDROMES WITH NEW ANTIEPILEPTIC DRUGS - John M. Pellock, Pediatrics 1999 104: 1106-1116
11. MECHANISMS OF ANTICONVULSANT DRUG ACTION. I: DRUGS PRIMARILY USED FOR GENERALIZED TONIC-CLONIC AND PARTIAL EPILEPSIES - C.L Faingold et al., Eur. J. Pediatr., 146:2-7 1987
12. MECHANISMS OF ANTICONVULSANT DRUG ACTION. II: DRUGS PRIMARILY USED FOR ABSENCE EPILESY - C.L Faingold et al., Eur. J. Pediatr., 146:8-14 1987
13. PHARMACOLOGY OF ANTIEPILEPTIC DRUGS - J.A Ferrendelli., Epilepsia, 28 (suppl. 3):S14-S16 1987
14. PHARMACOLOGY OF ANTIEPILEPTIC DRUGS - G.L Holmes., In: Diagnosis and Management of Seizures in Children Vol.30, Saunders 1987
15. HEPATOXICITY OF ANTIEPILEPTIC DRUGS - P.M Jeavons., In: Antiepileptic Therapy: Chronic Toxicity of Antiepileptic Drugs edited by J. Oxley et al., Raven Press 1983
16. EFFICACY AND ADVERSE EFFECTS OF ESTABLISHED AND NEW ANTIEPILEPTIC DRUGS - R.H Mattson et al., Epilepsia., 36 (suppl.1):S13-S26 1995
17. ANTIEPILEPTIC DRUGS IN PEDIATRIC PRACTICE - B.F.D Bourgeois., Epilepsia., 36:S34-S45 1995
18. NEW ANTICONVULSANT DRUGS: FOCUS ON FLUNARIZINE, FOSPHENYTOIN, MIDAZOLAM AND STIRIPENTOL - M. Bebin et al., Drugs., 48:153-171 1994
19. THERAPEUTIC DRUG MONITORING: A COMPREHENSIVE CRITICAL REVIEW OF ANALYTICAL METHODS FOR ANTICONVULSIVE DRUGS - A.H Kumps., J. Neurol.,228:1-16 1982
20. SEIZURES INDUCED OR AGGRAVATED BY ANTICONVULSANTS - P Lerman., Epilepsia., 27:706-710 1986
21. HIGH-DOSE MONOTHERAPY IN TREATMENT OF INTRACTABLE SEIZURES - R.P Lesser et al., Neurology., 34:707-711 1984
22. DRUG-INDUCED HYPERSENSITIVITY SYNDROME IN PEDIATRIC PATIENTS - M. C. Carroll et al., Pediatrics., 108: 485-492 2001
23. DRUG TREATMENT OF UNCONTROLLED SEIZURES - R.H Mattson., In: Surgical Treatment of Epilepsies, (Epi. Res. Suppl.5) edited by W.H Theodore., Elsevier 1992
24. OUTCOME AFTER DISCONTINUATION OF AED THERAPY IN CHILDREN WITH EPILEPSY - M. Atricardi et al., Epilepsia., 30:582-589 1989
25. COMPARATIVE MONOTHERAPY TRIAL IN CHILDREN WITH EPILEPSY - M.E.L McGowan et al., Brit. J. Clin. Prac., suppl. 27:115-119 1983
26. DRUG-INDUCED SEIZURES: A 10 YEAR EXPERIENCE - R.O Messing et al., Neurology., 34:1582-1586 1984
27. COMPARATIVE EFFICACY OF ANTIEPILEPTIC DRUGS - M.A Mikati et al., Clinical Neuropharmacology., 11:130-140 1988
28. KNOWLEDGE, ATTITUDE AND PRACTICE IN ANTIEPILEPTIC DRUG MONITORING - J.W.A Meijer., Acta. Neurol. Scand., 83 (suppl. 134):1-128 1991
29. ANTIEPILEPTIC DRUGS AND VITAMIN D SUPPLEMENTATION - G. Offerman et al., Epilepsia., 20:3-15 1979
© 2001-2007 Epiweb.org